Skip to NavigationSkip to content


A campaign to raise PCT awareness of the new Primary Care Drug Dictionary (PCCD) has been launched to promote its uptake among GPs and pharmacy IT...
AstraZeneca Crestor is to receive an immediate launch in its first market after Canada regulator approved the new cholesterol lowering drug.
Fears of a humanitarian crisis in Iraq are growing as civilians are forced to flee or stay in the heavily bombarded cities of Basra and Baghdad.
GlaxoSmithKline has received mixed news in the on-going patent battle with Canadian generics company Apotex over its biggest selling drug,...
Pfizer's blockbuster hypertension and angina treatment Norvasc could face competition from a related drug following a US court ruling.
The poorest performing NHS hospitals could now be run by private companies under new plans unveiled by the Government.
The safety and efficacy of new surgical and non-surgical interventions are to be assessed as part of a new NICE programme aimed at protecting...
Galen has bolstered its product range by buying the rights to pre-menstrual syndrome treatment Sarafem from Lilly for $295 million.
ReNeuron, the UK biopharmaceutical company specialising in stem cells and neurological disorders, is in discussions with a potential merger partner.
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches